Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Other Non Operating Income (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Other Non Operating Income data on record, last reported at $70000.0 in Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 900.0% year-over-year to $70000.0; the TTM value through Oct 2025 reached $206000.0, up 36.42%, while the annual FY2025 figure was $73000.0, 52.08% up from the prior year.
  • Other Non Operating Income reached $70000.0 in Q4 2025 per CSBR's latest filing, down from $75000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $81000.0 in Q2 2024 and bottomed at -$105000.0 in Q4 2023.
  • Average Other Non Operating Income over 5 years is $11450.0, with a median of $10500.0 recorded in 2023.
  • Peak YoY movement for Other Non Operating Income: tumbled 1066.67% in 2023, then surged 1400.0% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $26000.0 in 2021, then tumbled by 134.62% to -$9000.0 in 2022, then crashed by 1066.67% to -$105000.0 in 2023, then surged by 106.67% to $7000.0 in 2024, then soared by 900.0% to $70000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $70000.0 in Q4 2025, $75000.0 in Q3 2025, and $43000.0 in Q2 2025.